Health In Tech Inc【HIT】株式ニュース

Health In Tech Announces Fourth Quarter and Full Year 2025 Financial ResultsMarch 25, 2026 4:05 PM
PR Newswire (US)

Full year 2025 Revenues of $33.3 million, up 71% YoYFull year 2025 Adjusted EBITDA of $4.1 million, up 81% YoYSTUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Financial Highlights for the Full Year 2025 and Fourth Quarter of 2025: Revenues. Full year 2025 revenues were $33.3 million, up 71% year over year ("YoY"). Q4 revenues were $7.5 million, up 53% YoY.Adjusted EBITDA. Full year 2025 Adjusted EBITDA was $4.1 million, up 81% YoY, Q4 Adjusted EBITDA of $0.3 million compared to prior year Q4 Adjusted EBITDA of $0.5 million.Net Income. Full year 2025 net income was $1.3 million, up 91% YoY, Q4 net loss of $0.3 million compared to prior year Q4 net loss of $0.1 million.Billed Enrolled Employees. The number of billed enrolled employees (EEs) was 22,515 as of December 31, 2025, up 23% YoY.Distribution. The number of Brokers, Third-party Administrator ("TPAs") and Agencies expanded to 858 partners as of December 31, 2025, up 34% YoY.Cash. Cash balance was $7.7 million as of December 31, 2025.Revenue OutlookHealth In Tech expects full-year 2026 revenue to be in the range of $45 million to $50 million, representing year-over-year growth of approximately 35% to 50%. This outlook is based on management's current expectations and assumptions, including continued strong demand for the Company's AI-enabled underwriting marketplace across the self-funded health insurance segment and successful deployment of new features. Actual results may differ materially due to risks and uncertainties described in Health In Tech's filings with the SEC.The Company expects continued growth driven by expanding engagement across its distribution network and the full deployment of new features launched in January 2026. Unlike the traditional insurance industry, where new product and service implementations typically require one to two years, Health In Tech's AI-driven platform enables new capabilities to be developed and deployed within approximately one to two quarters. This accelerated development cycle provides a meaningful competitive advantage, allowing the Company to respond quickly to broker and client demand, continuously enhance its marketplace offerings, and scale its technology platform more efficiently than traditional market participants.CEO Commentary Tim Johnson, Chief Executive Officer of Health In Tech, commented, "2025 was a defining year of disciplined execution and measurable platform scale for Health In Tech. We strengthened our AI-enabled underwriting marketplace, expanded carrier, broker, and TPA integrations, and further automated core insurance workflows to drive efficiency and margin scalability. We extended underwriting capabilities into larger employer segments and continued enhancing our technology architecture to support enterprise-level throughput across the approximately $300 billion U.S. claims administration market. Most importantly, we translated operational progress into financial performance, delivering 71% year-over-year revenue growth."Mr. Johnson continued, "As we enter 2026, our focus is on advancing a fully integrated marketplace model that expands beyond underwriting to include additional services such as claims administration and administrative cost-containment solutions. Building on years of assembling specialized healthcare vendors and service providers essential to self-funded plans, we enhanced our platform in January 2026 to offer more than 100 pre-configured, customized stop-loss programs tailored at the broker-agency level. This structured program architecture enables agencies to align standardized offerings with target employer segments, empowering brokers to deliver execution-ready solutions with greater speed, consistency, and operational efficiency. The result is shorter sales cycles, improved conversion visibility, and scalable distribution leverage, while maintaining the flexibility to customize for employer-specific needs."In the first half of 2026, we expect to complete market testing of our Three-Year Rate stabilization program, designed to provide cost stability and predictability for eligible employer groups. We also plan to initiate beta testing of a new data-driven solution that integrates physiological data and claims data to generate actionable value insights. Together, these initiatives reflect our strategy of layering incremental, high-value services onto an already commercialized and scalable platform to drive durable growth and increasing operating leverage."Key Developments in Q1 2026 Engaged Amazon Web Services (AWS) Advanced Tier Services Partner Ciklum to accelerate development of Health In Tech's AI-Driven InsurTech platform.Appointed former SAP and IBM executive Sri Rajagopalan as Chief Technology Officer to advance AI-driven Enterprise-Grade platform growth.Appointed five-time founder Zain Hasan as Chief Growth Officer to accelerate revenue growth and scale distribution.Introduced 100+ pre-configured stop-loss self-funded healthcare plans for employers, streamlining the renewal process and reducing cycle times.Hosted the inaugural independent hitDavos InsurTech Summit during World Economic Forum Week 2026, driving brand visibility and global leadership engagement across the government, technology, healthcare, and finance sectors.Conference Call DetailsHealth In Tech will host a conference call to discuss the financial results for the fourth quarter and full year of 2025 on March 25, 2026, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).A live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.Non-GAAP Financial InformationThis release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Management uses Adjusted EBITDA to provide investors with additional insight into operational performance and to facilitate comparison with other companies in the industry. Adjusted EBITDA should not be considered an alternative to net income, operating income, or other GAAP measures. A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.Use of Forward-Looking StatementsCertain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.About Health In Tech Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration. Learn more at healthintech.com. Health In Tech, Inc.Consolidated Statements of Operations

Three Months Ended
December 31,
Fiscal Year Ended December 31,

2025
2024
2025
2024
Revenues

Revenues from underwriting modeling
(ICE)
$1,032,381
$1,697,080
$6,864,545
$6,649,271

Revenues from fees
6,476,204
3,207,484
26,462,966
12,841,635

    SMR
6,476,204
2,470,284
26,462,966
9,849,300

    HI Card
-
737,200
-
2,992,335

Total revenues
7,508,585
4,904,564
33,327,511
19,490,906

Cost of revenues
3,379,942
1,107,173
12,389,783
4,051,439

Gross profit
4,128,643
3,797,391
20,937,728
15,439,467

Operating expenses

Sales and marketing expenses
906,206
632,060
4,185,766
3,158,257

General and administrative expenses
3,180,137
2,848,014
13,654,262
8,477,407

Research and development expenses
213,113
633,653
1,569,262
2,813,899

Total operating expenses
4,299,456
4,113,727
19,409,290
14,449,563

Other income (expense):

Interest income
104,659
28,774
409,922
122,885

Interest expenses
-
-
-
(495,000)

Other income
-
114,055
118,399
271,211

Other expense
(377,587)
62,759
(382,587)
-

Total other income (expense), net
(272,928)
205,588
145,734
(100,904)

Income (loss) before income tax
expense
$(443,741)
$(110,748)
$1,674,172
$889,000

Provision for income taxes
141,184
(33,404)
(395,330)
(218,523)

Net income (loss)
$(302,557)
$(144,152)
$1,278,842
$670,477

Net income per share

Basic
$(0.01)
$(0.00)
$0.02
$0.01

Diluted
$(0.01)
$(0.00)
$0.02
$0.01

Weighted average common stocks
outstanding

Basic
56,908,999
52,047,723
55,843,821
51,839,329

Diluted
58,635,562
54,662,931
57,742,798
53,662,677

  Health In Tech, Inc.Consolidated Balance Sheets

December 31, 2025
December 31, 2024
Assets

Current assets

Cash and cash equivalents
$7,669,754
$7,849,248

Accounts receivable, net
756,288
1,647,103

Loans receivable, net
815,995
-

Other receivables, net
3,467,814
500,252

Deferred offering costs
170,977
-

Prepaid expenses and other current assets
3,280,148
787,161

Total current assets
16,160,976
10,783,764

Non-current assets

Software
6,530,894
3,962,461

Loans receivable, net
-
815,995

Operating lease - right of use assets
139,940
206,269

Long-term prepaid expenses
258,151
-

Total non-current assets
6,928,985
4,984,725

Total assets
$23,089,961
$15,768,489

Liabilities and stockholders' equity

Current liabilities

Accounts payable and accrued expenses
$4,188,811
$1,858,840

Income taxes payable
-
205,253

Operating lease liabilities - current
76,195
66,881

Other current liability
891,598
-

Total current liabilities
5,156,604
2,130,974

Non-current liabilities

Deferred tax liabilities
757,675
328,676

Operating lease liabilities - non-current
63,617
139,811

Total non-current liabilities
821,292
468,487

Total liabilities
5,977,896
2,599,461

Stockholders' equity

Common stock, $0.001 par value; Class A Common
stock 150,000,000 shares authorized 46,006,000 and
42,914,870 shares issued and outstanding as of
December 31, 2025 and December 31, 2024,
respectively
46,006
42,915

Common stock, $0.001 par value; Class B Common
stock 50,000,000 shares authorized, 11,700,000
shares issued and outstanding as of December 31,
2025 and December 31, 2024, respectively
11,700
11,700

Additional paid-in capital
11,834,121
9,173,017

Retained earnings
5,220,238
3,941,396

Total stockholders' equity
17,112,065
13,169,028

Total liabilities and stockholders' equity
$23,089,961
$15,768,489

  Health In Tech, Inc.Consolidated Statements of Cash Flows

Fiscal Year Ended December 31,

2025
2024CASH FLOWS FROM OPERATING ACTIVITIES:

Net income
$1,278,842
$670,477
Adjustments to reconcile net income to net cash provided by
(used in) operating activities:

Bad debt expense (recovery)
(16,234)
1,878
Amortization expense
900,577
541,141
Provision for refund liability
3,891,598
-
Provision for credit losses on other receivables
377,587
-
Deferred tax expenses (benefits)
428,999
(93,304)
Amortization of debt discount
-
495,000
Interest income
(64,000)
(63,996)
Stock-based compensation expense
1,570,419
468,489
Changes in operating assets and liabilities:

Accounts receivable
907,049
586,685
Other receivables
(3,345,149)
1,180,848
Prepaid expenses and other assets
(1,948,184)
(514,242)
Operating lease right of use assets and liabilities, net
(551)
1,889
Accounts payable and accrued expenses
2,358,113
(851,963)
Income taxes payable
(205,253)
(246,693)
Other current liabilities
(3,000,000)
-
Net cash provided by operating activities
3,133,813
2,176,209
CASH FLOWS FROM INVESTING ACTIVITIES:

Development of software
(3,189,921)
(900,755)
Interest received from loans receivable
64,000
64,000
Net cash used in investing activities
(3,125,921)
(836,755)
CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from issuance of common stock in connection with
initial public offering, net of underwriting discounts and
commissions
-
8,214,000
Proceeds from stock option exercises
23,430
-
Payments of deferred offering costs
(210,816)
(1,975,556)
Repayments of notes payable
-
(2,145,000)
Net cash provided by (used in) financing activities
(187,386)
4,093,444
Increase (decrease) in cash and cash equivalents
(179,494)
5,432,898
Cash and cash equivalents, beginning of year
7,849,248
2,416,350
Cash and cash equivalents, end of year
7,669,754
7,849,248
Supplemental disclosures of cash flow information:

Cash paid for interest
$-
$-
Cash paid for income taxes
$830,726
$558,521
Summary of noncash investing and financing activities:

Accrued deferred offering costs included in accounts
payable and accrued expenses
$-
$39,839
Accrued development of software included in accounts
payable and accrued expenses
$38,363
$50,000
Reclassification of deferred offering costs to additional paid-
in capital upon initial public offering
$-
$2,277,164
Stock-based compensation capitalized for software
development
$290,726
$-
  Health In Tech, Inc.Reconciliation of GAAP (Net Income) to Non-GAAP Financial Measure (Adjusted EBITDA)

Three Months Ended December 31,
Fiscal Year EndedDecember 31,

2025
2024
2025
2024Net income
(302,557)
(144,152)
1,278,842
670,477Interest (income) expenses
(104,659)
(28,774)
(409,922)
372,115Amortization expense
410,630
135,983
900,577
541,141Income tax expense
(141,184)
33,404
395,330
218,523Stock-based compensation expense
76,733
468,489
1,570,419
468,489Provision for credit losses on other
receivables
377,587
-
377,587
-Total net adjustments
619,107
609,102
2,833,991
1,600,268

Adjusted EBITDA
316,550
464,950
4,112,833
2,270,745 Investor Contact:
Health In Tech Investor Relations
ir@healthintech.comThe Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
kahl@theequitygroup.comDevin Sullivan, Managing Director
dsullivan@theequitygroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-fourth-quarter-and-full-year-2025-financial-results-302725203.htmlSOURCE Health In Tech Inc.

Original: Health In Tech Announces Fourth Quarter and Full Year 2025 Financial Results

Health In Tech and Amazon Web Service Advanced Tier Service Partner Ciklum Announce Strategic Collaboration to Accelerate Development of AI-Driven InsurTech PlatformMarch 17, 2026 4:01 PM
PR Newswire (US)

STUART, Fla., March 17, 2026 /PRNewswire/ -- Health In Tech, Inc. (the "Company" or "Health In Tech") (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced a strategic collaboration with Ciklum, a global AI-powered experience engineering and software development firm, to enhance the Company's AI-driven InsurTech platform. The HIT's platform operates as an integrated self-funded stop-loss health insurance marketplace serving more than 800 insurance brokers, third party administrators (TPAs), managing general underwriters (MGUs) and carriers in 40 states.

Ciklum's collaboration will optimize the platform's administrative, sales, and analytics capabilities. This initiative will expand both front- and back-end functionality to create an integrated technology environment—from AI-driven bindable quotes to AI-enabled financial reporting and analytics—while streamlining data infrastructure and reporting processes which all hosted on Amazon Web Services (AWS).Ciklum, an AWS Advanced Tier Services Partner, provides enterprise-grade software engineering services to Fortune 500 companies and high-growth technology organizations worldwide. Through this collaboration, Health In Tech expects to leverage Ciklum's deep technical expertise in AWS architecture, data engineering, and AI-driven software development to accelerate platform innovation and scalability.The Company anticipates successful implementation of these enhancements will deliver expected benefits including:Enhanced platform capabilities and administrative functions, enabling service partners to more efficiently support existing clients while potentially expanding into larger employer marketsImproved integration of front- and back-end workflows, consolidating quoting, underwriting, administration, and analytics into a unified platform with the goal of increasing usability and adoptionAdvanced data, operational reporting capabilities, which aims to deliver deeper insights and improved decision-making for brokers, TPAs, MGUs, carriers, and employer clientsTim Johnson, Chief Executive Officer of Health In Tech, commented, "Health in Tech was founded on the belief that self-funded stop-loss insurance should be simple, streamlined, and widely available. Consistent with our commitment to continuous improvement, we are thrilled to partner with Ciklum, a premier technical and software development company that possesses a full range of capabilities and expertise on our cloud platform, AWS. In addition to achieving AWS Advanced Tier Service partner status, Ciklum has accumulated deep domain experience across healthcare and health insurance and stands out through its AI-powered approach to experience engineering. Together, we are building integrated solutions designed to eliminate fragmented workflows and multiple system dependencies, improving the user experience for brokers, administrators, MGU and carrier partners. This collaboration reflects the strategic technology investments we are making today with the goal of supporting greater platform adoption, stronger customer retention, and long-term revenue growth.""Health in Tech is redefining how self-funded stop-loss insurance is delivered, bringing simplicity, transparency, and scalability to a complex ecosystem," said Raj Radhakrishnan, CEO of Ciklum. "At Ciklum, we are excited to partner with innovators that use technology to reshape industries. By combining Health in Tech's vision with our deep healthcare expertise, cloud-native engineering on AWS, and our Prodigy AI framework, we are building solutions that unify fragmented systems and deliver breakthrough improvements in operational efficiency.This partnership will leverage our years of experience and track record in delivering scalable AI-native platforms for leading enterprises, and we look forward to driving innovation and long-term impact for Health In Tech's customers and partners."About Ciklum Ciklum (www.ciklum.com) is a global experience engineering firm that stands at the forefront of innovation, blending next-generation product engineering, exceptional customer experiences, and cutting-edge AI. It revolutionizes the way people live by developing groundbreaking technologies that reimagine, reshape, and redefine the future. For more than two decades, Ciklum has been a trusted partner to both global enterprises and digital disruptors, spearheading the creation of digital solutions that not only tackle complex corporate challenges but also propel businesses toward accelerated growth and success. Ciklum has a vast global team of over 4,000 highly skilled engineers, experience design specialists, product owners and consultants.About Health In Tech Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration. Learn more at healthintech.com.Forward Looking StatementsThis press release may contain forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity. Health In Tech undertakes no obligation to update any forward-looking statements, except as required by lawInvestor Contact:
Health In Tech Investor Relations
ir@healthintech.com
The Equity GroupKalle Ahl, CFA
T: (303) 953-9878
kahl@theequitygroup.comDevin Sullivan, Managing Director
dsullivan@theequitygroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-and-amazon-web-service-advanced-tier-service-partner-ciklum-announce-strategic-collaboration-to-accelerate-development-of-ai-driven-insurtech-platform-302716452.htmlSOURCE Health In Tech Inc.

Original: Health In Tech and Amazon Web Service Advanced Tier Service Partner Ciklum Announce Strategic Collaboration to Accelerate Development of AI-Driven InsurTech Platform